// App-Quantinova.ai

: TRANSIENT SUBCLONES CARRYING NT5C2 MUTATIONS DEFINE A HIGH-RISK PATIENT GROUP WITH POOR OUTCOME IN PEDIATRIC RELAPSED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Malwine J. Pogodzinski

Principal Investigators

  • Jana Hof

  • Stefanie Groeneveld-Krentz

  • Annabell Szymansky

  • Arend von Stackelberg

  • Adolfo A. Ferrando

  • Cornelia Eckert

  • Renate Kirschner-Schwabe

Medical Centers

  • Department of Pediatric Oncology/Hematology, Charite Medical University Berlin, Berlin, Germany.

  • Institute for Cancer Genetics, Columbia University, New York, NY

  • Department of Pediatric Oncology and Hematology,Charite - Universitaetsmedizin,Berlin,Germany;German Cancer Consortium (DKTK),German Cancer Research Center (DKFZ),Heidelberg,Germany

Locations

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved